Loading...

Heidelberg Pharma AG

HPHA.DEXETRA
Healthcare
Biotechnology
4.15
-0.23(-5.25%)

Heidelberg Pharma AG (HPHA.DE) Financial Performance & Income Statement Overview

Review Heidelberg Pharma AG’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.

Revenue Growth
-30.53%
30.53%
Operating Income Growth
-15.79%
15.79%
Net Income Growth
4.74%
4.74%
Operating Cash Flow Growth
12.13%
12.13%
Operating Margin
-373.97%
373.97%
Gross Margin
64.14%
64.14%
Net Profit Margin
-303.90%
303.90%
ROE
-62.67%
62.67%
ROIC
-54.24%
54.24%

Heidelberg Pharma AG (HPHA.DE) Income Statement & Financial Overview

Review Heidelberg Pharma AG's (HPHA.DE) income statement with detailed quarterly and annual figures.

MetricQ1 2025Q4 2024Q3 2024Q2 2024
Revenue$1.27M$1.60M$1.19M$2.79M
Cost of Revenue$267770.00$505777.00$141366.00$1.54M
Gross Profit$1.003M$1.10M$1.05M$1.25M
Gross Profit Ratio$0.79$0.68$0.88$0.45
R&D Expenses$6.61M$6.19M$5.07M$5.51M
SG&A Expenses$1.38M$1.79M$1.75M$1.52M
Operating Expenses$7.99M$7.98M$7.02M$7.03M
Total Costs & Expenses-$8.26M-$8.49M$7.16M$8.57M
Interest Income$181863.00$310577.00$372359.00$378597.00
Interest Expense$1533.00$1093.00$1548.00$37269.00
Depreciation & Amortization$223659.00$221787.00$214865.00$216873.00
EBITDA-$5.71M-$4.90M-$5.38M-$3.97M
EBITDA Ratio-$4.50-$3.06-$4.51-$1.42
Operating Income-$6.99M-$6.88M-$5.96M-$5.79M
Operating Income Ratio-$5.50-$4.30-$5.00-$2.08
Other Income/Expenses (Net)$1.05M$1.76M$370809.00$341329.00
Income Before Tax-$5.94M-$5.12M-$5.59M-$4.22M
Income Before Tax Ratio-$4.67-$3.20-$4.69-$1.51
Income Tax Expense$0.00$0.00$0.00-$48931.00
Net Income-$5.94M-$5.12M-$5.59M-$4.17M
Net Income Ratio-$4.67-$3.20-$4.69-$1.50
EPS-$0.13-$0.11-$0.12-$0.09
Diluted EPS-$0.13-$0.11-$0.12-$0.09
Weighted Avg Shares Outstanding$46.60M$46.60M$45.07M$46.60M
Weighted Avg Shares Outstanding (Diluted)$46.60M$46.60M$45.07M$46.60M

Unlock 25+ Years of Financial Data

Get access to extended historical data, advanced metrics, and more with our premium plan

Frequently Asked Questions

;